Pramipexole to Improve Cognition in Bipolar Disorder: A Randomized Controlled Trial

BACKGROUND: Adults with bipolar disorder (BD) often experience neurocognitive impairment that negatively impacts functioning and quality of life. Previous trials have found that dopamine agonist agents improve cognition in healthy volunteers and that adults with BD who have stable mood and mild cogn...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Psychopharmacol
Autors principals: Van Meter, Anna R., Perez-Rodriguez, M. Mercedes, Braga, Raphael J., Shanahan, Megan, Hanna, Lauren, Malhotra, Anil K., Burdick, Katherine E.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2021
Matèries:
Original Contributions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238822/
https://ncbi.nlm.nih.gov/pubmed/33956703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000001407
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars